CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES Koller, M., Flanagan, K., Skov, M., Goldblum, R., Griffith, S. G., Barbour, R. M., Ehsani-Chimeh, N., Marinkovich, M. P., Zago, W., Yednock, T. A., Kinney, G. G., Ness, D. BMJ PUBLISHING GROUP. 2016: 134

View details for DOI 10.1136/annrheumdis-2016-eular.3570

View details for Web of Science ID 000401523100385